# OnCo record survivorship-roadmap (roadmap). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/roadmaps/survivorship-roadmap/>
  a schema:CreativeWork ;
  onco:kind "roadmap" ;
  schema:identifier "survivorship-roadmap" ;
  schema:name "Supportive care and survivorship roadmap: making treatment bearable → proving it extends life → caring for tens of millions afterwards"@en ;
  schema:description "Supportive care began as the drugs that let people get through chemotherapy. It is now a discipline with randomised proof that exercise, early palliative care and symptom monitoring lengthen life, and its next task is organised lifelong care for the growing population of people living after cancer."@en ;
  schema:url <https://onco.cc/roadmaps/survivorship-roadmap/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.nejm.org/doi/full/10.1056/NEJMoa2502760>, <https://ccss.stjude.org>, <http://www.survivorshipguidelines.org> ;
  onco:related <https://onco.cc/ideas/idea-acc-risk-stratified-follow-up/>, <https://onco.cc/ideas/idea-acc-auto-generated-survivorship-plans/>, <https://onco.cc/ideas/idea-acc-national-late-effects-registry/>, <https://onco.cc/ideas/idea-moon-adult-late-effects-registry/>, <https://onco.cc/ideas/idea-acc-tailored-second-cancer-screening/>, <https://onco.cc/ideas/idea-acc-risk-stratified-cardio-oncology-pathway/>, <https://onco.cc/ideas/idea-moon-cardioprotection-by-default/>, <https://onco.cc/ideas/idea-reg-financial-toxicity-vital-sign/>, <https://onco.cc/ideas/idea-acc-return-to-work-rehabilitation/>, <https://onco.cc/ideas/idea-acc-nurse-led-follow-up-clinics/>, <https://onco.cc/ideas/idea-moon-fertility-preservation-default/>, <https://onco.cc/ideas/idea-acc-lymphoedema-prospective-surveillance/>, <https://onco.cc/ideas/idea-bio2-cachexia-function-endpoint/>, <https://onco.cc/ideas/idea-moon-cachexia-as-treatable-disease/>, <https://onco.cc/ideas/idea-acc-survivor-biobank-late-effect-prediction/>, <https://onco.cc/ideas/idea-moon-open-pro-data-commons/>, <https://onco.cc/ideas/idea-nl-exercise-dose-finding/>, <https://onco.cc/ideas/idea-moon-neuropathy-prevention-programme/>, <https://onco.cc/ideas/idea-moon-pro-ctcae-in-every-pivotal-trial/>, <https://onco.cc/ideas/idea-moon-supportive-care-arpa/>, <https://onco.cc/ideas/idea-fund-survivorship-endowment-levy/>, <https://onco.cc/ideas/idea-fund-cachexia-programme/>, <https://onco.cc/ideas/idea-acc-automatic-early-palliative-triggers/>, <https://onco.cc/ideas/idea-acc-geriatric-assessment-by-default/>, <https://onco.cc/ideas/idea-moon-survivor-lifelong-care-model/>, <https://onco.cc/ideas/idea-moon-peer-navigator-workforce/>, <https://onco.cc/roadmaps/nutrition-lifestyle-roadmap/>, <https://onco.cc/roadmaps/prostate-roadmap/>, <https://onco.cc/ideas/idea-prostate-other-cause-mortality-as-a-reported-service-outcome/> ;
  onco:sections <https://onco.cc/fronts/supportive-care/>, <https://onco.cc/fronts/rejuvenation/> ;
  onco:technologies <https://onco.cc/technologies/g-csf-growth-factors/>, <https://onco.cc/technologies/infusion-devices-vascular-access/>, <https://onco.cc/technologies/pain-management/>, <https://onco.cc/technologies/hospice-end-of-life/>, <https://onco.cc/technologies/palliative-care/>, <https://onco.cc/technologies/remote-patient-monitoring/>, <https://onco.cc/technologies/geriatric-assessment/>, <https://onco.cc/technologies/cardio-oncology/>, <https://onco.cc/technologies/fertility-preservation/>, <https://onco.cc/technologies/survivorship-care-plan/>, <https://onco.cc/technologies/exercise-oncology/>, <https://onco.cc/technologies/structured-exercise-survivorship/>, <https://onco.cc/technologies/prehabilitation/>, <https://onco.cc/technologies/psycho-oncology/>, <https://onco.cc/technologies/scalp-cooling/>, <https://onco.cc/technologies/integrative-oncology/>, <https://onco.cc/technologies/cbt-insomnia-cancer/>, <https://onco.cc/technologies/lymphoedema-decongestive-therapy/>, <https://onco.cc/technologies/cachexia-therapy/>, <https://onco.cc/technologies/cachexia-appetite-pharmacotherapy/>, <https://onco.cc/technologies/resistance-training-cachexia/>, <https://onco.cc/technologies/oncology-nutrition/>, <https://onco.cc/technologies/cancer-associated-thrombosis/>, <https://onco.cc/technologies/minoxidil-chemotherapy-alopecia/> ;
  onco:drugs <https://onco.cc/drugs/sodium-thiosulfate/>, <https://onco.cc/drugs/dexrazoxane/> ;
  onco:trials <https://onco.cc/trials/ccss/>, <https://onco.cc/trials/challenge/>, <https://onco.cc/trials/prehab-trial/>, <https://onco.cc/trials/olanzapine-appetite-tmh/>, <https://onco.cc/trials/ponsegromab-phase-2/>, <https://onco.cc/trials/romana-1-2/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-survivorship/>, <https://onco.cc/bottlenecks/b-cachexia-supportive/>, <https://onco.cc/bottlenecks/b-toxicity-qol/>, <https://onco.cc/bottlenecks/b-aging-comorbidity/>, <https://onco.cc/bottlenecks/b-palliative/>, <https://onco.cc/bottlenecks/b-funding-allocation/> ;
  onco:journals <https://onco.cc/journals/journal-of-cancer-survivorship/> .